Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President and CEO, Director, 10%+ Owner
-
Stock Symbol
-
ACXP on Nasdaq
David P. Luci - trading volume in the past year for Acurx Pharmaceuticals, Inc.
Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
1.1M |
$1.11M |
$1.02 |
Jan 6, 2025 |
Direct |
|
|
Common Stock |
35K |
$35.5K |
$1.02 |
Jan 6, 2025 |
By child |
|
|
Common Stock |
15.1K |
$15.3K |
$1.02 |
Jan 6, 2025 |
By spouse |
|
|
Stock Option |
250K |
|
|
Feb 5, 2025 |
Direct |
Common Stock |
|
Stock Option |
250K |
|
|
Feb 23, 2024 |
Direct |
Common Stock |
|
Warrants for Common Stock |
49.3K |
|
|
Jan 6, 2025 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.